Related Experiment Video
Updated: Apr 25, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Neonatal vitamin K refusal and nonimmunization.
Vanita Sahni1, Florence Y Lai1, Shannon E MacDonald2
1Alberta Health Surveillance and Assessment, Edmonton, Alberta, Canada;
Parents who refuse vitamin K for newborns are significantly more likely to refuse childhood immunizations. This study identifies characteristics of these parents to improve intervention strategies for both vitamin K and vaccine uptake.
Area of Science:
- Pediatrics
- Public Health
- Epidemiology
Background:
- Neonatal Vitamin K prophylaxis prevents vitamin K deficiency bleeding.
- Parental refusal of vitamin K prompted investigation into its prevalence and association with subsequent immunization refusal.
Purpose of the Study:
- To determine the prevalence and characteristics of parents who refuse vitamin K for their infants.
- To assess the association between vitamin K refusal and subsequent refusal of childhood immunizations.
Main Methods:
- Retrospective population-based cohort study using linked administrative health data (Alberta, 2006-2012).
- Poisson regression used to identify risk factors for vitamin K refusal.
- Relative risk assessed the association between vitamin K refusal and non-immunization.
Main Results:
- 0.3% of 282,378 infants declined vitamin K prophylaxis.
- Vitamin K refusal was associated with midwife-assisted delivery, planned home birth, or birth center delivery.
- Vitamin K refusal increased the relative risk of no childhood vaccines at 15 months by 14.6-fold.
Conclusions:
- First population-based study characterizing parents who refuse vitamin K and whose children remain unimmunized.
- Findings allow earlier identification of high-risk parents.
- Opportunities exist to implement strategies for increasing uptake of vitamin K and childhood immunizations.
Related Concept Videos
Vitamins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion

